| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 8 | 2019 | 33 | 2.750 |
Why?
|
| HIV-1 | 26 | 2015 | 678 | 2.560 |
Why?
|
| Virus Replication | 19 | 2019 | 261 | 2.220 |
Why?
|
| Exons | 2 | 2018 | 80 | 1.170 |
Why?
|
| Apolipoproteins | 3 | 2015 | 19 | 1.140 |
Why?
|
| Lipoproteins, HDL | 3 | 2015 | 43 | 1.120 |
Why?
|
| Kidney Diseases | 4 | 2019 | 159 | 1.000 |
Why?
|
| Kidney Glomerulus | 2 | 2019 | 80 | 0.820 |
Why?
|
| Alternative Splicing | 2 | 2018 | 82 | 0.770 |
Why?
|
| Cytidine Deaminase | 3 | 2010 | 31 | 0.760 |
Why?
|
| Nucleotidyltransferases | 1 | 2019 | 10 | 0.740 |
Why?
|
| Nucleosomes | 1 | 2019 | 27 | 0.730 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2015 | 251 | 0.730 |
Why?
|
| BK Virus | 1 | 2019 | 5 | 0.720 |
Why?
|
| Polyomavirus Infections | 1 | 2019 | 20 | 0.710 |
Why?
|
| Gene Products, tat | 8 | 2004 | 34 | 0.700 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 287 | 0.680 |
Why?
|
| Phosphoproteins | 1 | 2019 | 154 | 0.670 |
Why?
|
| RNA Splice Sites | 1 | 2018 | 10 | 0.660 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 14 | 0.650 |
Why?
|
| Postoperative Complications | 1 | 2019 | 206 | 0.640 |
Why?
|
| Exosomes | 2 | 2010 | 97 | 0.630 |
Why?
|
| Signal Transduction | 8 | 2019 | 1802 | 0.620 |
Why?
|
| DNA | 1 | 2019 | 549 | 0.580 |
Why?
|
| Membrane Microdomains | 4 | 2004 | 46 | 0.570 |
Why?
|
| Membrane Proteins | 1 | 2019 | 486 | 0.550 |
Why?
|
| Cell Line | 11 | 2017 | 1289 | 0.540 |
Why?
|
| Interferons | 6 | 2013 | 34 | 0.530 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2002 | 325 | 0.500 |
Why?
|
| Autophagy | 1 | 2015 | 111 | 0.490 |
Why?
|
| Receptors, HIV | 2 | 2010 | 5 | 0.460 |
Why?
|
| Immunity, Innate | 1 | 2013 | 135 | 0.450 |
Why?
|
| T-Lymphocytes | 6 | 2011 | 341 | 0.410 |
Why?
|
| Virus Activation | 3 | 2019 | 35 | 0.410 |
Why?
|
| Humans | 41 | 2019 | 34853 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2000 | 27 | 0.400 |
Why?
|
| Gene Expression Regulation, Viral | 4 | 1998 | 108 | 0.390 |
Why?
|
| Virus Internalization | 1 | 2010 | 27 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2002 | 122 | 0.380 |
Why?
|
| Gene Products, gag | 2 | 2013 | 12 | 0.380 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2010 | 7 | 0.380 |
Why?
|
| Cytosine Deaminase | 1 | 2010 | 6 | 0.380 |
Why?
|
| Alu Elements | 1 | 2010 | 8 | 0.370 |
Why?
|
| Endocytosis | 4 | 2013 | 104 | 0.370 |
Why?
|
| Transcription, Genetic | 8 | 2017 | 550 | 0.360 |
Why?
|
| HIV Envelope Protein gp120 | 6 | 2004 | 54 | 0.360 |
Why?
|
| AIDS-Associated Nephropathy | 2 | 2018 | 13 | 0.310 |
Why?
|
| Cytokines | 3 | 2019 | 569 | 0.310 |
Why?
|
| Receptors, CXCR4 | 4 | 2002 | 67 | 0.300 |
Why?
|
| Herpesvirus 1, Human | 3 | 1994 | 54 | 0.270 |
Why?
|
| HIV Infections | 4 | 2015 | 2207 | 0.260 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 968 | 0.260 |
Why?
|
| Receptors, Chemokine | 2 | 2002 | 68 | 0.260 |
Why?
|
| Nucleocapsid Proteins | 1 | 2004 | 9 | 0.250 |
Why?
|
| Transforming Growth Factor beta | 3 | 1991 | 183 | 0.250 |
Why?
|
| Genetic Variation | 2 | 2017 | 328 | 0.240 |
Why?
|
| RNA, Messenger | 5 | 2017 | 1152 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2018 | 386 | 0.230 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 181 | 0.220 |
Why?
|
| Receptors, CCR5 | 2 | 2002 | 59 | 0.220 |
Why?
|
| Cell Line, Transformed | 2 | 2019 | 87 | 0.220 |
Why?
|
| beta-Cyclodextrins | 1 | 2002 | 22 | 0.220 |
Why?
|
| Chemokine CCL5 | 2 | 2018 | 38 | 0.220 |
Why?
|
| Membrane Lipids | 1 | 2002 | 31 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 2 | 2002 | 162 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 40 | 0.210 |
Why?
|
| Transfection | 3 | 2015 | 496 | 0.210 |
Why?
|
| Cells, Cultured | 12 | 2015 | 1442 | 0.200 |
Why?
|
| Base Sequence | 5 | 2015 | 932 | 0.200 |
Why?
|
| Proteins | 1 | 2004 | 352 | 0.200 |
Why?
|
| Cell Membrane | 1 | 2003 | 360 | 0.200 |
Why?
|
| Transforming Growth Factors | 4 | 1988 | 4 | 0.200 |
Why?
|
| Fibroblasts | 4 | 1991 | 252 | 0.200 |
Why?
|
| HIV Long Terminal Repeat | 5 | 2001 | 19 | 0.190 |
Why?
|
| Genes, tat | 3 | 1994 | 8 | 0.180 |
Why?
|
| Amino Acid Sequence | 5 | 2015 | 1124 | 0.180 |
Why?
|
| Proviruses | 3 | 2000 | 27 | 0.180 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 8 | 2004 | 52 | 0.170 |
Why?
|
| Interferon-gamma | 2 | 1998 | 235 | 0.170 |
Why?
|
| Interferon-beta | 1 | 2018 | 7 | 0.170 |
Why?
|
| Simian immunodeficiency virus | 1 | 1998 | 56 | 0.170 |
Why?
|
| Protein Kinases | 1 | 1998 | 91 | 0.170 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 85 | 0.160 |
Why?
|
| Cell Dedifferentiation | 1 | 2018 | 5 | 0.160 |
Why?
|
| Protein Isoforms | 1 | 2018 | 121 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 185 | 0.160 |
Why?
|
| Retroviridae | 2 | 2010 | 22 | 0.160 |
Why?
|
| NF-kappa B | 5 | 1998 | 306 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 121 | 0.160 |
Why?
|
| Enzyme Activation | 4 | 2000 | 423 | 0.150 |
Why?
|
| Cholesterol | 3 | 2011 | 194 | 0.150 |
Why?
|
| Defective Viruses | 2 | 1994 | 10 | 0.150 |
Why?
|
| Microscopy, Confocal | 4 | 2013 | 210 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 1996 | 42 | 0.150 |
Why?
|
| Macrophages | 4 | 2013 | 431 | 0.150 |
Why?
|
| ras Proteins | 1 | 1996 | 49 | 0.140 |
Why?
|
| Interferon Type I | 3 | 1992 | 17 | 0.140 |
Why?
|
| Glucose | 1 | 2018 | 217 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2017 | 562 | 0.140 |
Why?
|
| Jurkat Cells | 3 | 2002 | 72 | 0.140 |
Why?
|
| DNA, Viral | 4 | 2008 | 295 | 0.140 |
Why?
|
| Deoxyribonucleotides | 1 | 2015 | 11 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 16 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2018 | 366 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 54 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 52 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2013 | 392 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 229 | 0.130 |
Why?
|
| Phospholipase D | 1 | 2015 | 47 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1490 | 0.130 |
Why?
|
| Benzodiazepinones | 1 | 1994 | 21 | 0.130 |
Why?
|
| Viral Proteins | 3 | 2008 | 172 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 146 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 1992 | 164 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 222 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 376 | 0.120 |
Why?
|
| Pyrroles | 1 | 1994 | 54 | 0.120 |
Why?
|
| Peptides | 2 | 1987 | 308 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 225 | 0.120 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2013 | 7 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2013 | 21 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 416 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2004 | 485 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 1994 | 148 | 0.110 |
Why?
|
| Microtubules | 1 | 2013 | 113 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 2004 | 55 | 0.110 |
Why?
|
| Apoptosis | 4 | 2015 | 1317 | 0.110 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 1991 | 7 | 0.110 |
Why?
|
| Simplexvirus | 1 | 1991 | 10 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 480 | 0.100 |
Why?
|
| Encephalomyocarditis virus | 1 | 1991 | 2 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 1991 | 45 | 0.100 |
Why?
|
| Virus Release | 1 | 2010 | 7 | 0.100 |
Why?
|
| Protein Binding | 4 | 2011 | 913 | 0.090 |
Why?
|
| Plasmids | 2 | 2010 | 233 | 0.090 |
Why?
|
| DNA Primers | 3 | 2011 | 269 | 0.090 |
Why?
|
| Homeostasis | 1 | 2011 | 172 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 430 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 383 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2010 | 112 | 0.090 |
Why?
|
| Pinocytosis | 3 | 2005 | 8 | 0.090 |
Why?
|
| Animals | 14 | 2018 | 14307 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 1998 | 97 | 0.080 |
Why?
|
| Mitogens | 1 | 1988 | 10 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 1998 | 94 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2015 | 834 | 0.080 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 1998 | 9 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 1988 | 47 | 0.080 |
Why?
|
| Cell Division | 4 | 1991 | 296 | 0.080 |
Why?
|
| Clone Cells | 1 | 1987 | 46 | 0.080 |
Why?
|
| Mice | 8 | 2018 | 5668 | 0.080 |
Why?
|
| G(M1) Ganglioside | 2 | 2002 | 13 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2017 | 123 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 1996 | 484 | 0.060 |
Why?
|
| Nucleoside Deaminases | 1 | 2004 | 7 | 0.060 |
Why?
|
| Gene Products, vif | 1 | 2004 | 6 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 51 | 0.060 |
Why?
|
| Lentivirus | 1 | 2004 | 20 | 0.060 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2004 | 12 | 0.060 |
Why?
|
| Endosomes | 1 | 2004 | 34 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 229 | 0.060 |
Why?
|
| Virus Assembly | 1 | 2004 | 38 | 0.060 |
Why?
|
| Coronary Vessels | 2 | 2004 | 93 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 83 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 175 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2003 | 24 | 0.060 |
Why?
|
| Palmitic Acid | 1 | 2003 | 24 | 0.060 |
Why?
|
| Glycosylation | 1 | 2003 | 92 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 74 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 240 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 1 | 2004 | 139 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 1998 | 522 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 200 | 0.060 |
Why?
|
| Lipids | 1 | 2004 | 222 | 0.060 |
Why?
|
| Cocaine | 1 | 2005 | 219 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 286 | 0.060 |
Why?
|
| Cyclodextrins | 1 | 2002 | 9 | 0.050 |
Why?
|
| RNA | 1 | 2004 | 234 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2004 | 226 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 165 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 298 | 0.050 |
Why?
|
| Binding Sites | 3 | 1998 | 597 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 1988 | 649 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 197 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 2000 | 22 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1149 | 0.050 |
Why?
|
| Arteries | 1 | 2001 | 67 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 214 | 0.050 |
Why?
|
| Myocardium | 1 | 2002 | 224 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2013 | 350 | 0.050 |
Why?
|
| Butadienes | 1 | 2000 | 30 | 0.050 |
Why?
|
| Nitriles | 1 | 2000 | 66 | 0.050 |
Why?
|
| Virus Integration | 1 | 2000 | 49 | 0.050 |
Why?
|
| Biological Transport | 1 | 2000 | 175 | 0.040 |
Why?
|
| Gene Expression | 2 | 1993 | 639 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 454 | 0.040 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 1998 | 3 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 1998 | 18 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1998 | 14 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1998 | 14 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 24 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 52 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2004 | 878 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 93 | 0.040 |
Why?
|
| Brain | 2 | 2005 | 1268 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 33 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 1998 | 28 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 186 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 35 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 73 | 0.040 |
Why?
|
| RNA, Viral | 2 | 2004 | 287 | 0.040 |
Why?
|
| PAX2 Transcription Factor | 1 | 2018 | 2 | 0.040 |
Why?
|
| WT1 Proteins | 1 | 2018 | 4 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 605 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1998 | 135 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2000 | 351 | 0.040 |
Why?
|
| Calcitriol | 1 | 2018 | 30 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 396 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 420 | 0.040 |
Why?
|
| Hela Cells | 3 | 1995 | 344 | 0.040 |
Why?
|
| Receptors, Calcitriol | 1 | 2018 | 59 | 0.040 |
Why?
|
| Growth Substances | 2 | 1988 | 16 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2017 | 51 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1996 | 10 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 122 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 282 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2017 | 156 | 0.040 |
Why?
|
| Kinetics | 2 | 1996 | 650 | 0.040 |
Why?
|
| Virion | 1 | 1996 | 67 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 608 | 0.040 |
Why?
|
| Antibodies | 1 | 1996 | 135 | 0.040 |
Why?
|
| Antigens, CD | 1 | 1996 | 116 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 984 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 650 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1995 | 19 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1995 | 37 | 0.030 |
Why?
|
| Retroviridae Proteins | 1 | 1994 | 7 | 0.030 |
Why?
|
| Genes, rev | 1 | 1994 | 2 | 0.030 |
Why?
|
| Polyribosomes | 1 | 1994 | 3 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 12 | 0.030 |
Why?
|
| DNA Replication | 1 | 2015 | 148 | 0.030 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 74 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1994 | 116 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 107 | 0.030 |
Why?
|
| Genome, Viral | 1 | 1994 | 103 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 641 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 1987 | 336 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 45 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 39 | 0.030 |
Why?
|
| Blood-Brain Barrier | 2 | 2005 | 153 | 0.030 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1991 | 8 | 0.030 |
Why?
|
| Cattle | 2 | 1995 | 472 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1991 | 16 | 0.030 |
Why?
|
| Transcription Factors, TFII | 1 | 2011 | 2 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1991 | 60 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1993 | 224 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1991 | 69 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1991 | 63 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1991 | 152 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1991 | 137 | 0.020 |
Why?
|
| Transcription Factors | 1 | 1994 | 653 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1989 | 46 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1989 | 161 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 195 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1989 | 74 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 1988 | 150 | 0.020 |
Why?
|
| Trypsin | 1 | 1988 | 39 | 0.020 |
Why?
|
| Agar | 1 | 1987 | 8 | 0.020 |
Why?
|
| Amino Acids | 1 | 1988 | 139 | 0.020 |
Why?
|
| Rabbits | 1 | 1988 | 278 | 0.020 |
Why?
|
| Chromatography | 1 | 1987 | 15 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3414 | 0.020 |
Why?
|
| Cats | 1 | 1987 | 65 | 0.020 |
Why?
|
| Hormones | 1 | 1986 | 51 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 3261 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2005 | 23 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 16 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1987 | 166 | 0.020 |
Why?
|
| Permeability | 1 | 2005 | 67 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1987 | 239 | 0.020 |
Why?
|
| Kidney | 1 | 1987 | 322 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 145 | 0.020 |
Why?
|
| Dextrans | 1 | 1984 | 17 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 125 | 0.020 |
Why?
|
| Coloring Agents | 1 | 1984 | 51 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 126 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 132 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 90 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 194 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 16 | 0.010 |
Why?
|
| Heparin | 1 | 2002 | 34 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 323 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 39 | 0.010 |
Why?
|
| Pregnancy | 1 | 1987 | 1503 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 859 | 0.010 |
Why?
|
| Gene Products, pol | 1 | 2001 | 2 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 296 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1681 | 0.010 |
Why?
|
| Chemokines | 1 | 2001 | 89 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 642 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 1534 | 0.010 |
Why?
|
| Chimera | 1 | 1995 | 15 | 0.010 |
Why?
|
| Vero Cells | 1 | 1995 | 90 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1994 | 26 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 249 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 1994 | 145 | 0.010 |
Why?
|
| Monocytes | 1 | 1995 | 258 | 0.010 |
Why?
|
| Male | 1 | 1987 | 18870 | 0.010 |
Why?
|
| Female | 1 | 1987 | 19873 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 84 | 0.000 |
Why?
|
| Species Specificity | 1 | 1986 | 233 | 0.000 |
Why?
|
| Insulin | 1 | 1986 | 224 | 0.000 |
Why?
|
| Drug Stability | 1 | 1984 | 110 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1984 | 342 | 0.000 |
Why?
|